Clinical Trials Browser

Terminated × INDUSTRY × brivanib × Clear all

NCT04212221 2024-07-23

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Phase 1/2 Terminated

89 enrolled 23 charts

Gastrointestinal

Advanced Hepatocellular Carcinoma (HCC)

NCT01108705 2015-10-12

BRISK-APS

Phase 3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

NCT00300027 2010-03-02

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

Phase 1 Terminated

Gastrointestinal

Gastrointestinal Neoplasms